https://www.laduenews.com/front-and-center/health/the-future-of-pfizer-and-the-innovative-st-louisans-at-the-center-of-creating-pfizer/article_78675bf0-70fc-555c-99f1-d3d2f2bfa942.html#tracking-source=home-the-latest

The Future of Pfizer

by Brittany Nay, Ladue News - February 18, 2022

“St. Louis scientists at global biotech company Pfizer played a crucial role in creating its COVID-19 vaccine. LN recently spoke with Justin Sperry, site lead at the company’s research and development facility in Chesterfield and vice president of transformational technology for biotherapeutics and vaccines, to learn more about Pfizer’s innovative response to the pandemic.”

“Describe your site’s role in creating Pfizer’s COVID-19 vaccine.”

“The St. Louis site was responsible for two key activities during the COVID-19 vaccine development: one involving the manufacturing of a key starting material, and the other in developing the testing strategies for the entire vaccine process.”

Key starting material??

“. . . What is your site currently working on?”

“In addition to the many other biological medicines for oncology, inflammation, rare disease and vaccines in the portfolio, the St. Louis site works on our RNA platform of technologies and products. We continue to support the approved vaccine, along with the current clinical program for an RNA flu vaccine. An omicron-specific vaccine [has started] clinical trials. “

approved vaccine??? I thought it was still experimental stage and for Emergency Use Only???

Pfizer Inc.

875 Chesterfield Parkway West

Chesterfield, MO

pfizer.com